Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the “Most Streamed Artiste of 2019’’

Must Read

List of United Bank for Africa (UBA) Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...

List of Access Bank Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number which usually identifies both the bank and the branch where an account is...

List of First Bank of Nigeria Sort Codes in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...
- Advertisement -

As 2019 draws to a close, it’s a good time to reflect on favourite songs, playlist, artistes and even albums of the year. Based on data, Boomplay, the #1 music streaming service in Africa has put together a report detailing music facts in Nigeria for the year 2019.

Boomplay boasts of over 60 million users globally – 17 million of which are from Nigeria and an expansive catalogue of over 20M tracks.

So, what were Nigerians listening to in 2019?

After an impressive year with the release of his Album – African Giant, Burna Boy claimed the spot of the most-streamed artist in Nigeria. Tope Alabi, Kizz Daniel, Teni and Naira Marley round out the top-five most-streamed artists.

- Advertisement -

The year’s top song comes from Tope Alabi with “Yes And Amen” claiming the spot for most-streamed song of 2019.  After Uyo Meyo by Teni, You are Yaweh by Steve Crown, Madu by Kizz Daniel, the year’s most-streamed song came from Naira Marley with his viral song Soapy.

Tope Alabi’s “Yes And Amen ”racked up as the most-streamed album of 2019 followed by Kizz Daniel’s “No Bad Songz, Burna Boy’s African Giant, Tobe Alabi and TY Bello’s collaboration “The Spirt & Light” claiming the fourth spot and Moral Instruction by Falz being fifth.

Read Also:  BURNA BOY, DAVIDO, OTHERS TOP 2019 AFRIMA FINAL NOMINATIONS LIST

Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand Spur

Ed Sheeran’s collaboration with Justin Bieber “I Don’t Care claimed the spot of the most-streamed international song in Nigeria while Don Moen topped as a most-streamed international artiste in Nigeria.

- Advertisement -

Christian and Gospel was the most listened-to genre that dominated 2019 with Afrobeats experiencing following right after.

These information and more are available in the 2019 Boomplay Music Facts Nigeria! Take a look at some of the top songs, artists, genres, and trends. Did your favourite artist, song, album or playlist make it? Let us know!

Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand Spur Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand Spur Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand Spur Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand Spur

- Advertisement -
Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand SpurBoomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand Spur

Subscribe to BrandSpur Ng

Subscribe for latest updates. Signup to best of brands and business news, informed analysis and opinions among others that can propel you, your business or brand to greater heights.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand SpurBoomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand Spur

Latest News

DEBx Medical Receives CE Mark Clearance and ISO 13485 Certification for Debrichem(R), a Novel Desiccant Gel for Chemical Debridement to Initiate Healing in Infected,...

  • Debrichem(R) offers a very effective, alternative approach to chronic wound care, initiating healing in more than 90 % of cases after one application[1]
  • CE mark and ISO 13485:2016 certification are important prerequisites for upcoming launches in markets worldwide
  • Chronic wounds affect 1 - 2 % of developed countries' populations,[2] unsuccessful treatment may lead to enlargement of the wound, bone involvement or in the worst case, amputation[3]
  • Debrichem soon to be launched in Europe, Hong Kong, South Africa, New Zealand and Australia


ROTTERDAM, THE NETHERLANDS - EQS Newswire - 25 February 2021 - DEBx Medical, the Dutch medical technology company revolutionizing the management of chronic wounds, is excited to highlight today the successful completion of the CE conformity assessment procedure for Debrichem(R). The innovative topical agent offers a superior alternative to surgical debridement, the current standard of care. Debrichem can now carry the CE mark for a medical device class IIb and has also been awarded ISO 13485:2016 certification. These certifications endorse the quality and safety of Debrichem to treat a high unmet medical need and the strength of the DEBx Medical team to achieve this quickly even in such difficult times. DEBx Medical plans first to launch Debrichem in Europe, South Africa as well as Hong Kong, New Zealand and Australia through a network of distribution partners; other markets will follow. DEBx Medical has started consultations with the FDA about the pathway to approval earlier this year.

Debrichem is a topical desiccant gel for chemical wound debridement used for the treatment of chronic infected and/or necrotic wounds. This novel product desiccates (dehydrates) the biofilm and the pathogens in the wound bed, debriding the biofilm chemically instead of surgically. Surrounding healthy skin is not affected.[4] The data underlying the CE mark approval show that, after a one-time 60-second application, more than 90 % of wounds result in full granulation,1 an important step in the healing process.[5] Due to its fast action and applicability outside the surgery room, Debrichem can easily be integrated within standard wound care procedures.4

"Being granted the CE mark and ISO 13485 certification for Debrichem in less than two years after founding DEBx Medical is an exciting and important milestone. I am proud of our achievements and would like to thank the whole team involved in this huge effort," said Dr. Bertus Quint, founding CEO of DEBx Medical. "Chronic wounds are painful and debilitating and patients have very limited options for healing. With Debrichem, we set out to significantly improve this situation which is frustrating for healthcare professionals and patients alike. We believe that Debrichem has the potential to meaningfully improve health outcomes and quality of life for millions of patients worldwide."

Read Also:  2019 Already Looking Like A Great Year For Burna Boy, As Star Lager Unveils New Commercial

"In my day-to-day work, I experience the patients' despair associated with chronic wounds and the doctors' frustration with their inability to provide patients long-term healing. With the current COVID-19 pandemic, the situation has been exacerbated: many of our patients are in high-risk groups - elderly, diabetic or chronic cardiovascular patients - who now cannot go to the hospital for their urgently needed treatment," said David L. Helfet, MD, Professor of Orthopaedic Surgery, Weill Cornell Medical College and Hospital for Special Surgery, New York Presbyterian Hospital. "The major advantage of Debrichem is that with a relatively simple, quick, one time application it destroys the biofilm. Removing the biofilm is absolute key to get chronic wounds to heal. Debrichem is an important step forward in the management of chronic wounds and will find its place in the standard of care in a very short time. It may even have the potential to become the new gold standard for debridement in chronic wound care."

Chronic wounds are defined as wounds that have not healed, at least in part, after 4 to 12 weeks.[6] Physiologically, healing of chronic wounds is corrupted, among other factors, by excess inflammation and a recurrent or persistent, if not drug-resistant, microbial infection, often in the biofilm on a wound bed.4 The current gold standard treatment, maintenance surgical debridement, is a painful procedure performed in a sterile environment. Surgical debridement does not reliably initiate healing of the wound but can be part of an extensive wound management program requiring patients to repeatedly come into the hospital. Not surprisingly, general quality of life is impaired in patients with chronic wounds.6 Chronic wounds are estimated to have a prevalence of up to 2 % in the general population.[7] The wound etiology has an impact on outcome, arterial ulcers and venous leg ulcers are notoriously difficult to heal. Chronic wounds are also a common comorbidity of diabetes,[8] 13 % of patients with diabetes in North America to 17 % in Belgium are suffering from chronic wounds.[9] The burden of chronic wounds to healthcare systems and society around the world is substantial, exacerbated by the high rate of amputation in especially diabetic patients which is close to 34 % for diabetic foot ulcers.8 In the UK alone, chronic wounds generated costs of GBP 5.6 bn in 2018. The total wound care costs in the UK increased annually by 8 - 9 % with chronic wounds accounting for the largest share.[10]

References
[1] Cogo A et al., J Wound Care 2020;29(Sup7b):63-64. https://doi.org/10.12968/jowc.2020.29.Sup7b.1
[2] Nussbaum SR et al., Value Health 2018;21:27-32. https://doi.org/10.1016/j.jval.2017.07.007
[3] Strohal R et al., J Wound Care 2013; 22 (Suppl. 1): S1-S52. https://doi.org/10.12968/jowc.2013.22.Sup1.S1
[4] Cogo A et al., Wounds 2021;33:1-8. https://www.woundsresearch.com/article/restarting-healing-process-chronic-wounds-using-novel-desiccant-prospective-case-series
[5]http://www.shieldhealthcare.com/community/popular/2015/12/18/how-wounds-heal-the-4-main-phases-of-wound-healing/
[6] Olsson M et al., Wound Repair Regen 2019;27(1):114-125. https://doi.org/10.1111/wrr.12683
[7] Martinengo L et al., Ann Epidemiol 2019;29:8-15. https://doi.org/10.1016/j.annepidem.2018.10.005
[8] McCosker L et al., Int Wound J 2019;16:84-95. https://doi.org/10.1111/iwj.12996
[9] Zhang P et al., Ann Med 2017;49:106-116. https://doi.org/10.1080/07853890.2016.1231932
[10] Guest JF et al., BMJ Open 2020;10:e045253. https://doi.org/10.1136/bmjopen-2020-045253


The issuer is solely responsible for the content of this announcement.


About Debrichem(R)

Debrichem(R) is a disruptive new treatment option to address the infection in chronic wounds. The topical agent offers a superior alternative to surgical debridement, the current standard of care. Debrichem has been demonstrated to remove the biofilm and the pathogens from the wound bed that disrupt the onset of the natural healing process. Out of the more than 1.000 patients treated so far, more than 90 % of chronic wounds started to heal after only one treatment with Debrichem.4 The product is applied in a fast and simple, non-invasive procedure. Healthcare professionals should always consider using local anesthetics when applying the treatment. Debrichem can be used outside a surgical environment which can be particularly useful in situations, such as during the COVID-19 pandemic, where patients cannot get to hospitals to undergo surgery, avoiding long-term complications like amputation. Debrichem will be sold through a worldwide network of distributors, with the first market launches expected in Q1 2021.


About DEBx Medical

DEBx Medical B.V. is a Dutch medical technology company dedicated to revolutionizing the management of chronic wounds by enabling their healing, thereby improving the outcomes for millions of patients. DEBx Medical supports doctors and their patients from diagnosis through treatment, follow-up care, and maintenance of a healthy wound bed. The Company focuses its pipeline on targeting pathogens that corrupt wound healing, aiming to deliver affordable and effective treatment approaches that can easily be applied and implemented in daily clinical practice. Debrichem(R), DEBx Medical's first product, received a CE mark in early 2021 and will be launched in markets around the world. Debrichem offers a disruptive approach to debridement that has been demonstrated to enable healing of chronic wounds in more than 90 % of cases.

Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand Spur
- Advertisement -
BrandsPur Weekly Cartoons
- Advertisement -Boomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand SpurBoomplay Presents: 2019 Music Facts Nigeria as Burna Boy bags the "Most Streamed Artiste of 2019’’ - Brand Spur